Hematogones With Lambda Light Chain Restriction in a 4-Year-Old Boy With Burkitt Lymphoma: A Potential Diagnostic

Tesha Guillory1, Shiyong Li1, Daniel J Bergsagel2

  • 1Department of Pathology, Emory University, Atlanta, GA.

Laboratory Medicine
|April 13, 2016
PubMed

Insights

Hematogones, immature B cell precursors, typically lack surface immunoglobulin light chains. This case highlights rare hematogones exhibiting lambda light chain restriction, posing diagnostic challenges for B cell lymphoproliferative disorders.

Area of Science:

  • Hematology
  • Immunology
  • Pediatric Oncology

Background:

  • Hematogones are normal B cell precursors identified by flow cytometry.
  • They typically lack surface immunoglobulin light chain expression.
  • Distinguishing reactive hematogones from malignant B cells is crucial in pediatric oncology.

Purpose of the Study:

  • To report a rare case of hematogones with light chain restriction.
  • To emphasize potential diagnostic pitfalls in bone marrow workups for B cell lymphoproliferative disorders.
  • To increase awareness among clinicians regarding atypical hematogone immunophenotypes.

Main Methods:

  • Flow cytometry analysis of bone marrow aspirate.
  • Immunophenotyping using a panel of cell surface markers including CD10, CD19, CD22, CD38, CD58, HLA-DR, and CD45.
  • Assessment of surface immunoglobulin light chain expression (kappa and lambda).
  • Molecular studies for immunoglobulin gene rearrangements (heavy and kappa light chain).

Main Results:

  • A distinct population of cells with hematogone immunophenotype (dim CD10, CD19, CD22, CD38, dim CD58, HLA-DR, dim CD45) was identified.
  • These hematogones exhibited dim surface immunoglobulin lambda light-chain restriction.
  • Molecular studies for immunoglobulin heavy and kappa light-chain gene rearrangements were negative.

Conclusions:

  • Hematogones can rarely display light chain restriction, mimicking malignant B cell populations.
  • This finding presents a diagnostic challenge in the evaluation of pediatric bone marrow samples.
  • Awareness of this phenomenon is essential to avoid misdiagnosis of B cell lymphoproliferative disorders.

Related Concept Videos